hAESCs Prevent Acute Graft-versus-host Disease After Hematopoietic Stem Cell Transplantation

Stopped The research content involving the use of hAESCs for the prevention of aGVHD after HSCT has completed the IND application for treating the said condition. Therefore, an application is submitted to terminate this research project.

Conditions

• Acute Graft Versus Host Disease

Interventions

• BIOLOGICAL: Human amniotic epithelial stem cells（hAESCs）
• BIOLOGICAL: placebo (cell preservation solution)

Sponsor

Nanfang Hospital, Southern Medical University

Collaborators

• [object Object]